Policy experts look at curbing healthcare spending by encouraging comparison shopping in exchange for cash back; the home healthcare industry worries about immigration policy changes; the promise of a universal flu vaccine is still elusive.
Shopping for care and getting money back is gaining more acceptance, Kaiser Health News reported. The practice began with some state health plans and is now being discussed more widely among some policy makers and in the private sector as a way to curb healthcare spending by steering patients to more cost-effective providers for non-emergency care.
The home healthcare industry is worrying there won't be enough workers to care for the nation's growing number of senior citizens, NPR reported. Congress and the White House are mulling immigration policy changes, including the administration's proposals for restricting legal immigrants, that could affect the industry. The policy change that would hurt the industry the most targets family reunification, according to the nonprofit sector representing long-term care. Others in favor of making immigration policy changes say such issues could be avoided if wages were increased and workers were treated better.
The United States is still a long way away from a universal flu vaccine, STAT reported. Scientists say many questions have to be answered before a vaccine can realistically be developed that can target all strains of the flu. Meanwhile, the CDC reported last week that the flu season appears to be waning.
Consumers should not eat precut cantaloupe if they do not know the source, as the number of illnesses and recalls tied to a deadly salmonella outbreak grows; the White House and the Department of Education urged schools to take proactive steps to prevent youth drug use; a study published this week found a high prevalence of arrhythmia in patients with long COVID.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma
November 30th 2023A real-world study suggests high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is feasible for appropriately selected elderly patients, with similar results seen in older and younger patients.
Read More
Study Highlights BMP7 as a Potential Therapeutic Target for Ovarian Cancer
November 30th 2023High Bone Morphogenetic Protein 7 (BMP7) expression was significantly associated with aggressive phenotypes, including advanced grade, International Federation of Gynecology and Obstetrics stage, residual disease, and adverse overall survival.
Read More